Ian Ahearn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows.

New yorkUnited statesComunidad autonoma de catalunaUniversity of texasUnited kingdomColumbia universityAudun kvalvaagRuimin panHong liangXiang peng kongJun wangIan ahearnChristina luoZhihua qinElliot philipsKadam mor